It is common for sponsors to switch digital platforms between clinical trial pha...
Two years after the FDA placed partial clinical hold, Avidity can resume researc...
The roadmap suggests those with the greatest clinical need will get priority acc...
Recordati has reached an agreement with Sanofi for acquiring the worldwide right...
Gilead Sciences has announced the signing of voluntary licencing agreements with...
Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foun...
GLP-1 RAs are being recommended on social media, raising questions about who can...
ImmunoPrecise Antibodies, an AI-driven biotherapeutic research and technology co...
Novaliq and Laboratoires Théa have announced approval from the European Commissi...
At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach b...
Resolution plans to use Series B investment to advance the development of its ma...
Novo Nordisk’s chief scientific officer Marcus Schindler led the keynote address...
Pfizer and Merck KGaA’s venture capital arms were among the backers in the Serie...
Discover the leading Healthcare Payers for the Pharmaceutical Industry. Download...
As part of the deal, which could be worth $3.5bn, BMS will gain developmental su...
Ascendis Pharma has submitted a supplemental biologics licence application (sBLA...
